These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31069869)

  • 1. CADM1 associates with Hippo pathway core kinases; membranous co-expression of CADM1 and LATS2 in lung tumors predicts good prognosis.
    Ito T; Nakamura A; Tanaka I; Tsuboi Y; Morikawa T; Nakajima J; Takai D; Fukayama M; Sekido Y; Niki T; Matsubara D; Murakami Y
    Cancer Sci; 2019 Jul; 110(7):2284-2295. PubMed ID: 31069869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
    Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
    Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
    Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
    Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway.
    Suh JH; Won KY; Kim GY; Bae GE; Lim SJ; Sung JY; Park YK; Kim YW; Lee J
    Int J Clin Exp Pathol; 2015; 8(11):14608-18. PubMed ID: 26823784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of a novel MAP4K4-LATS2-SASH1-YAP1 cascade inhibits tumorigenesis and metastasis in luminal breast cancer.
    Yang P; Li Y; Hou J; Wu D; Zeng X; Zeng Z; Zhang J; Xiong Y; Chen L; Yang D; Wan X; Wu Z; Jia L; Liu Q; Lu Q; Zou X; Fang W; Zeng X; Zhou D
    J Biol Chem; 2024 Jun; 300(6):107309. PubMed ID: 38657867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.
    Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B
    J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
    Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
    Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.
    Guo C; Wang X; Liang L
    Int J Clin Exp Pathol; 2015; 8(2):1690-7. PubMed ID: 25973055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer.
    Kim E; Ahn B; Oh H; Lee YJ; Lee JH; Lee Y; Kim CH; Chae YS; Kim JY
    Pathology; 2019 Apr; 51(3):261-267. PubMed ID: 30819540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP1-LATS2 feedback loop dictates senescent or malignant cell fate to maintain tissue homeostasis.
    He C; Lv X; Huang C; Hua G; Ma B; Chen X; Angeletti PC; Dong J; Zhou J; Wang Z; Rueda BR; Davis JS; Wang C
    EMBO Rep; 2019 Mar; 20(3):. PubMed ID: 30755404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low LATS2 expression is associated with poor prognosis in non-small cell lung carcinoma.
    Jang SH; Oh MH; Cho H; Lee JH; Lee H; Ahn H; Kim H
    Pol J Pathol; 2019; 70(3):189-197. PubMed ID: 31820862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl.
    Reuven N; Adler J; Meltser V; Shaul Y
    Cell Death Differ; 2013 Oct; 20(10):1330-40. PubMed ID: 23852372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors.
    Aguennouz M; Polito F; Visalli M; Vita G; Raffa G; Oteri R; Ghazi B; Scalia G; Angileri FF; Barresi V; Caffo M; Cardali S; Conti A; Macaione V; Bartolotta M; Giorgio RD; Germanò A
    Cancer Treat Res Commun; 2020; 24():100203. PubMed ID: 32777750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippo pathway and tumoral FOXP3 expression correlate with tumor growth in squamous cell carcinoma of the lung.
    Won KY; Kim HK; Kim GY; Song MJ; Lim SJ
    Pathol Res Pract; 2020 Jul; 216(7):153003. PubMed ID: 32534707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
    Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
    Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CADM1 is a TWIST1-regulated suppressor of invasion and survival.
    Hartsough EJ; Weiss MB; Heilman SA; Purwin TJ; Kugel CH; Rosenbaum SR; Erkes DA; Tiago M; HooKim K; Chervoneva I; Aplin AE
    Cell Death Dis; 2019 Mar; 10(4):281. PubMed ID: 30911007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
    Yan R; Liang ZW; Liu HS; Ge Y; An GY
    Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
    [No Abstract]   [Full Text] [Related]  

  • 19. MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway.
    Feng S; Sun H; Zhu W
    Clin Transl Oncol; 2021 Mar; 23(3):450-458. PubMed ID: 32654106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas.
    Luo SY; Sit KY; Sihoe AD; Suen WS; Au WK; Tang X; Ma ES; Chan WK; Wistuba II; Minna JD; Tsao GS; Lam DC
    Lung Cancer; 2014 Aug; 85(2):282-92. PubMed ID: 24976335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.